Monitoring and Living with CEAS Long-Term
At a Glance
For people with chronic enteropathy associated with SLCO2A1 (CEAS), long-term care includes regular checks for anemia and protein loss, imaging for scar-related small-bowel narrowing, and caution with capsule endoscopy. Nutrition and emotional support also help protect quality of life.
Living with chronic enteropathy associated with SLCO2A1 (CEAS) is a long-term journey that requires a shift in focus from “curing” the disease to active, vigilant management. Because CEAS is a chronic, relapsing condition, regular monitoring is the most effective way to catch complications before they become emergencies [1][2]. Your care team will focus on tracking your body’s vital resources and maintaining the physical openness of your small intestine.
Long-Term Blood Monitoring
Because CEAS causes a steady “leak” of blood and protein through intestinal ulcers, regular lab work is your first line of defense [3][4]. Even if you feel well, these markers can signal that your body needs extra support:
- Anemia Markers: You will likely need periodic Complete Blood Count (CBC) and ferritin tests to monitor for iron-deficiency anemia, which affected nearly 98% of patients in certain reported cohorts [1][3]. This monitoring schedule is highly individualized based on your symptoms, age, and treatment.
- Protein Levels: Regular checks of albumin and total protein are essential to monitor for protein-losing enteropathy [4][5]. A drop in albumin often explains why you might experience new swelling (edema) in your legs [1][3].
- Inflammatory Markers: It is important to remember that in CEAS, your C-reactive protein (CRP) may stay near normal even when ulcers are active [1][5]. Doctors will rely more on your iron/protein levels and your physical symptoms than on typical inflammatory markers [5].
Surveillance for Strictures
The small intestinal ulcers in CEAS have a tendency to scar over time, creating strictures (narrowed segments) [2][6]. Because these can form slowly, your doctor may recommend an individualized imaging plan, such as MR enterography (MRE) [2].
MRE is often preferred for long-term monitoring because it does not use radiation, making it safer for repeated use over many years [2]. These scans help your team see if any part of the bowel is becoming dangerously narrow or if the intestine above a narrowing is beginning to stretch (dilate), which is a warning sign of a future blockage [2]. However, MRE can sometimes miss short or subtle narrowings.
A Warning on Capsule Endoscopy
While “pill cameras” (capsule endoscopy) are useful for many digestive issues, they carry a specific risk for people with CEAS [7]. If you have an undiagnosed stricture, the capsule can become trapped, a complication called capsule retention [7][8].
- The Risk: A trapped capsule can lead to a bowel obstruction. This requires prompt medical management and can sometimes require emergency surgery to remove both the capsule and the narrowed segment of the bowel [7][9].
- Safety First: If a doctor suggests capsule endoscopy, they should first confirm the bowel is open using an MRE or a patency capsule (a dissolvable dummy capsule). However, even a patency capsule can itself cause obstruction in some cases [8][10]. If strictures are known or highly suspected, capsule use is generally contraindicated. Specialists may consider double-balloon enteroscopy, which allows direct viewing and potential dilation, but it is an invasive procedure with its own risks of bleeding and perforation [8][11].
Quality of Life and Daily Management
Managing a rare, chronic condition like CEAS can be physically and emotionally taxing. The persistent fatigue from anemia and the unpredictability of abdominal pain can impact your daily activities, work, and social life [12].
- Nutritional Support: Work with a dietitian who understands malabsorption. While no specific diet “cures” CEAS, maintaining adequate calorie and protein intake is vital for your energy [5][13].
- Psychological Impact: It is normal to feel frustrated or anxious when living with a condition that has no definitive cure and may require repeated procedures [12][14]. Connecting with reputable rare-disease organizations, genetic counselors, or therapists familiar with chronic illness can help you manage the mental burden of the diagnosis [12].
By staying consistent with your individualized monitoring and working closely with a gastroenterologist who specializes in small bowel diseases, you can manage the complications of CEAS and maintain a high quality of life.
Common questions in this guide
How often should I have blood tests for CEAS?
Why are albumin and total protein checked in CEAS?
How is small-bowel narrowing monitored in CEAS?
Is capsule endoscopy safe if I have CEAS?
Can my CRP be normal during a CEAS flare?
What can help me manage daily life with CEAS?
One line in your results can change your plan.
A C-reactive protein (CRP) result may not reflect active ulcers, so your doctor may rely more on iron and protein levels. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Chronic enteropathy associated with SLCO2A1 gene.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn's disease.
Umeno J, Esaki M, Hirano A, et al.
Journal of gastroenterology 2018; (53(8)):907-915 doi:10.1007/s00535-017-1426-y.
PMID: 29313109 - 2
A Novel Chronic Enteropathy Associated with SLCO2A1 Gene Mutation: Enterography Findings in a Multicenter Korean Registry.
Jeong B, Park SH, Ye BD, et al.
Korean journal of radiology 2023; (24(4)):305-312 doi:10.3348/kjr.2022.0684.
PMID: 36907595 - 3
Chronic enteropathy associated with solute carrier organic anion transporter family member 2A1 gene: A case report and review of literature.
Wang JY, Liu Y, Xu J, et al.
World journal of gastrointestinal endoscopy 2025; (17(12)):112344 doi:10.4253/wjge.v17.i12.112344.
PMID: 41479940 - 4
Clinical and Genetic Characteristics of Korean Patients Diagnosed with Chronic Enteropathy Associated with SLCO2A1 Gene: A KASID Multicenter Study.
Hong HS, Baek J, Park JC, et al.
Gut and liver 2022; (16(6)):942-951 doi:10.5009/gnl210415.
PMID: 35611666 - 5
Characteristics of chronic enteropathy associated with SLCO2A1 gene (CEAS) in children, a unique type of monogenic very early-onset inflammatory bowel disease.
Lim JG, Ko JS, Ko JM, et al.
BMC pediatrics 2024; (24(1)):396 doi:10.1186/s12887-024-04877-x.
PMID: 38890589 - 6
Chronic Enteropathy Associated With SLCO2A1 Gene [CEAS]-Characterisation of an Enteric Disorder to be Considered in the Differential Diagnosis of Crohn's Disease.
Hosoe N, Ohmiya N, Hirai F, et al.
Journal of Crohn's & colitis 2017; (11(10)):1277-1281 doi:10.1093/ecco-jcc/jjx068.
PMID: 28510689 - 7
A pediatric patient with chronic enteropathy associated with SLCO2A1 who underwent multimodal treatment including several surgeries: a case report.
Jung Y, Chung J, Yoo I
Frontiers in surgery 2025; (12()):1516960 doi:10.3389/fsurg.2025.1516960.
PMID: 40611925 - 8
Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.
Pennazio M, Spada C, Eliakim R, et al.
Endoscopy 2015; (47(4)):352-76 doi:10.1055/s-0034-1391855.
PMID: 25826168 - 9
Capsule retention: prevention, diagnosis and management.
Rondonotti E
Annals of translational medicine 2017; (5(9)):198 doi:10.21037/atm.2017.03.15.
PMID: 28567378 - 10
Retention of small bowel capsule endoscopy.
Rosa B, Dray X, Koulaouzidis A
Current opinion in gastroenterology 2023; (39(3)):227-233 doi:10.1097/MOG.0000000000000921.
PMID: 37144540 - 11
The role of small bowel endoscopy for Crohn's disease.
Chetcuti Zammit S, Ellul P, Sidhu R
Current opinion in gastroenterology 2019; (35(3)):223-234 doi:10.1097/MOG.0000000000000519.
PMID: 30844896 - 12
What we know about prostaglandin pathway dysfunction in chronic enteropathies: From endoscopy to molecular diagnosis.
Ruan S, Yan P, Yan Q, et al.
Journal of translational internal medicine 2026; (14(2)):204-224 doi:10.1515/jtim-2026-0020.
PMID: 42046811 - 13
Obscure gastrointestinal bleeding caused by congenital enteropathy in a Chinese young child-a case report.
Fang Y, Gu W, Luo Y, Chen J
BMC pediatrics 2020; (20(1)):438 doi:10.1186/s12887-020-02333-0.
PMID: 32943023 - 14
Crohn-like Disease Affecting Small Bowel Due to Monogenic SLCO2A1 Mutations: First Cases of Chronic Enteropathy Associated with SLCO2A1 Gene [CEAS] in France.
Hamon A, Cazals-Hatem D, Stefanescu C, et al.
Journal of Crohn's & colitis 2023; (17(5)):816-820 doi:10.1093/ecco-jcc/jjac181.
PMID: 36480694
This page is for informational purposes only and does not constitute medical advice. Your gastroenterologist and care team should tailor blood tests, imaging, nutrition, and procedures to your CEAS.